Cencora COR
NYSE COR
$309.02 -0.76 (-0.25%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cencora (COR) Gains from Sales and Divestitures (2009 - 2026)

Updated

Cencora (COR) reported Gains from Sales and Divestitures of -$1.28 million for fiscal Q3 2026 (quarter ended Jun 30, 2026).

Analysis

Cencora (COR) Gains from Sales and Divestitures (2009 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Cencora's Gains from Sales and Divestitures came in at $34.77 million; for FY2025 (ended Sep 30, 2025), it was -$35.54 million.

  • By fiscal year, Gains from Sales and Divestitures came in at $40.7 million in FY2023 (-27.6%) and $56.23 million in FY2022.
  • The fiscal Q3 2026 figure ranks as the lowest quarterly Gains from Sales and Divestitures since fiscal Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Unitedhealth 336.54 Bn 221.18 Bn 36.67 Bn
2 Cvs Health 110.50 Bn 63.10 Bn 47.23 Bn
3 Mckesson 105.27 Bn 91.73 Bn 3.69 Bn
4 Elevance Health 83.85 Bn -57.90 Bn 13.45 Bn
5 Cigna 71.48 Bn 41.02 Bn 14.97 Bn
6 Cencora 58.97 Bn 48.06 Bn 3.61 Bn
7 Cardinal Health 53.10 Bn 37.10 Bn 2.56 Bn
8 Humana 46.62 Bn -41.18 Bn 5.50 Bn
9 Centene 31.12 Bn -59.17 Bn 14.55 Bn
10 Molina Healthcare 9.86 Bn -25.01 Bn 1.43 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.28 Mn
Mar 31, 2026 234,000.00
Dec 31, 2025 35.82 Mn
Dec 31, 2024 -35.54 Mn
Sep 30, 2023 40.70 Mn
Sep 30, 2022 -3.77 Mn
Jun 30, 2022 60.00 Mn
Sep 30, 2016 -2.23 Mn
Sep 30, 2015 -3.83 Mn
Jun 30, 2015 -16.94 Mn
Sep 30, 2009 -6.42 Mn
API Access

Cencora Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=COR&period=max&api_key=YOUR_API_KEY